参考文献/References:
[1] Fernández-Real JM,McClain D,Manco M.Mechanisms linking glucose homeostasis and iron metabolism toward the onset and progression of type 2 diabetes[J].Diabetes Care,2015,38(11):2169-2176.DOI:10.2337/dc14-3082.
[2] Gao G,Li J,Zhang Y,et al.Cellular iron metabolism and regulation[J].Adv Exp Med Biol,2019,1173:21-32.DOI:10.1007/978-981-13-9589-5_2.
[3] Che J,Yang J,Zhao B,et al.The effect of abnormal iron metabolism on osteoporosis[J].Biol Trace Elem Res,2019,[Epub ahead of print].DOI:10.1007/s12011-019-01867-4.
[4] Grammer TB,Scharnagl H,Dressel A,et al.Iron metabolism, hepcidin, and mortality(the Ludwigshafen Risk and Cardiovascular Health Study)[J].Clin Chem,2019,65(7):849-861.DOI:10.1373/clinchem.2018.297242.
[5] Hu X,Cai X,Ma R,et al.Iron-load exacerbates the severity of atherosclerosis via inducing inflammation and enhancing the glycolysis in macrophages[J].J Cell Physiol,2019,234(10):18792-18800.DOI:10.1002/jcp.28518.
[6] Batchuluun B,Matsumata T,Batchuluun B,et al. Serum ferritin level is higher in poorly controlled patients with type 2 diabetes and people without diabetes, aged over 55 years[J].Diabet Med,2014,31(4):419-424.DOI:10.1111/dme.12343.
[7] Liu Y, Yang R, Liu J, et al.Fabrication, structure, and function evaluation of the ferritin based nanocarrier for food bioactive compounds[J].Food Chem,2019,299.
[8] Belo L,Rocha S,Valente MJ,et al. Hepcidin and diabetes are independently related with soluble transferrin receptor levels in chronic dialysis patients[J].Ren Fail,2019,41(1):662-672.DOI:10.1080/0886022X.2019.1635893.
[9] Zhou Y,Wu W,Xu Z,et al.Iron regulatory protein 2 deficiency may correlate with insulin resistance[J].Biochem Biophys Res Commun,2019,510(2):191-197.DOI:10.1016/j.bbrc.2019.01.022.
[10] Lee HJ,Choi JS,Lee HJ,et al.Effect of excess iron on oxidative stress and gluconeogenesis through hepcidin during mitochondrial dysfunction[J].J Nutr Biochem,2015,26(12):1414-1423.DOI:10.1016/j.jnutbio.2015.07.008.
[11] Yuan L,Lu CL,Wang Y,et al.Ang(1-7)protects islet endothelial cells from palmitate-induced apoptosis by AKT, eNOS, p38MAPK, and JNK pathways[J].J Diabetes Res,2014,2014:391476.DOI:10.1155/2014/391476.
[12] Andrews M,Soto N,Arredondo-Olguín M. Association between ferritin and hepcidin levels and inflammatory status in patients with type 2 diabetes mellitus and obesity[J].Nutrition,2015,31(1):51-57.DOI:10.1016/j.nut.2014.04.019.
[13] Vinchi F,Porto G,Simmelbauer A,et al. Atherosclerosis is aggravated by iron overload and ameliorated by dietary and pharmacological iron restriction[J].Eur Heart J,2019,[Epub ahead of print]. DOI:10.1093/eurheartj/ehz112.
[14] Whitehead M,Osborne A,Widdowson PS,et al.Angiopoietins in diabetic retinopathy:current understanding and therapeutic potential[J].J Diabetes Res,2019,2019:5140521.DOI:10.1155/2019/5140521.
[15] Song D,Zhao L,Li Y,et al.The oral iron chelator deferiprone protects against systemic iron overload-induced retinal degeneration in hepcidin knockout mice[J].Invest Ophthalmol Vis Sci,2014,55(7):4525-4532.DOI:10.1167/iovs.14-14568.
[16] Chaudhary K,Chilakala A,Ananth S,et al. Renal iron accelerates the progression of diabetic nephropathy in HFE(High Fe-iron)gene knockout mouse model of iron overload[J].Am J Physiol Renal Physiol,2019,[Epub ahead of print].DOI:10.1152/ajprenal.00184.2019.
[17] Zou C,Liu X,Liu R,et al.Effect of the oral iron chelator deferiprone in diabetic nephropathy rats[J]. J Diabetes,2017,9(4):332-340.DOI:10.1111/1753-0407.12420.
[18] Vincent AM,Callaghan BC,Smith AL,et al. Diabetic neuropathy: cellular mechanisms as therapeutic targets[J].Nat Rev Neurol,2011,7(10):573-583.DOI:10.1038/nrneurol.2011.137.
[19] Baum P,Kosacka J,Estrela-Lopis I,et al.The role of nerve inflammation and exogenous iron load in experimental peripheral diabetic neuropathy(PDN)[J].Metabolism,2016,65(4):391-405.DOI:10.1016/j.metabol.2015.11.002.
[20] Kosacka J,Woidt K,Toyka KV,et al.The role of dietary non-heme iron load and peripheral nerve inflammation in the development of peripheral neuropathy(PN)in obese non-diabetic leptin-deficient ob/ob mice[J].Neurol Res,2019,41(4):341-353.DOI:10.1080/01616412.2018.1564191.
[21] Klein D,Patzkó Á,Schreiber D,et al.Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice[J].Brain,2015,138(Pt 11):3193-3205.DOI:10.1093/brain/awv240.